Wednesday, 26 August 2015

The Pink Pill!

          The impotent male has had the Blue Pill for a long time now.  How much joy, delight and satisfaction it has brought to that group is questionable, but erections, like elections, are an essential part of our social culture.  But why should these droopy males, have all the advantages.  Legions of women who have derived little satisfaction from sex (after the wonder months or years) want to pop a pill just the way that those lucky, privileged, males have done for years now and find instant gratification!    And indeed, why shouldn't they?    I think, the very political correctness of the situation will make it an instant winner and barring any unsuspected side effects, above and beyond those already documented, will make a fortune for those bold enough to invest heavily in it.  

         Flibanserin (Addyi) is classified as a 5-HT serotonin receptor agonist and a dopamine D4 receptor partial agonist. It is a Non-Hormonal agent that increases dopamine and noradrenalin while reducing Serotonin in the brain.  It was being developed as a new antidepressant  and  a large number of women noticed an unexpected positive side effect from Flibanserin. Many woman were reporting more sexual interest and overall satisfying sexual experiences than before. One of the  main  side-effects of antidepressants is loss of libido, so  this provoked much interest.  Apparently some woman in the trials didn't want to stop the testing based on this fact alone.    This led the company to clinically testing this new compound for this exact reason. Can it actually increase a woman's desire for sex?
           Side effects that were reported by some of the users where usually low to moderate. These were dizziness, anxiety, fatigue, dry mouth, insomnia, nausea. Not everyone who partook in the study had any of these but there were more occasions of these being reported compared to the placebo group and due to the fact that this compound is fairly new, there have not been nor could there have been any long term studies on side effects
          Flibanserin (Addyi®) 100mg has been approved by the FDA. It is anticipated that it will be available by October 17th 2015.

No comments:

Post a Comment